Phoenix Eagle is a biopharmaceutical research and development company with a robust product pipeline based on its unique OPAL technology
Our patented OPAL technology has tested in a clinical setting and shown to be efficacious and safe, enabling for the gentle treatment of a variety of chronic conditions.
Our lead product, OPAL A, is derived from papaya fruit and has the potential to become the treatment of choice for a variety of chronic wounds and skin disorders. We’re only just beginning to uncover the true extent of OPAL A’s therapeutic and cosmetic capabilities.
Phoenix Eagle is a bio-pharmaceutical company developing disruptive technologies for the global wound healing and skin care markets.
Our patented OPAL process takes heated fruit and vegetable pulp and alkalises it to change its chemical and enzymatic composition.
Public presentation of OPAL001 and OPAL A
Register for free email alerts of news and announcements
Phoenix Eagle Company Pty Ltd Suite 5 531 Hay Street Subiaco, WA 6008 Australia Tel: 0419 094 748 Email: business@phoenixeaglecompany.com